Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies-Reference-Cited by-同舟云学术

Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies

Published:2017-06-12 Issue:6 Volume:18 Page:1258
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Yamaguchi Ryuji^ORCID,Perkins Guy

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/6/1258/pdf

Reference80 articles.

1. The transmission of leukemia of mice with a single cell;Furth;Am. J. Cancer,1937

2. Efficient tumour formation by single human melanoma cells

3. Exploring the Genomes of Cancer Cells: Progress and Promise

4. The genomic complexity of primary human prostate cancer

5. Finding a Panacea among Combination Cancer Therapies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Adipose-Derived Mesenchymal Stem Cell on the Expressions of Bax/Bcl-2, Ki67, VEGF, TNF-α, and Endometrial Implants in Metformin-Administered Endometriosis Mice (A Mouse Model in Endometriosis Study);Turkish Journal of Immunology;2021

2. CHALCONE - PROMISING ENTITY FOR ANTICANCER ACTIVITY: AN OVERVIEW;International Journal of Pharmaceutical Sciences and Research;2020-05-01

3. Decoding and targeting the molecular basis of MACC1-driven metastatic spread: Lessons from big data mining and clinical-experimental approaches;Seminars in Cancer Biology;2020-02

4. Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapy;Pharmacology & Therapeutics;2019-03